Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: Results from a prospective feasibility study [1]

Katsuyuki Hotta, Akira Inoue, Katsuyuki Kiura, Hiroshi Ueoka, Mitsune Tanimoto, Toshihiro Nukiwa

Research output: Contribution to journalLetterpeer-review

9 Citations (Scopus)
Original languageEnglish
Pages (from-to)413-415
Number of pages3
JournalLung Cancer
Issue number3
Publication statusPublished - Dec 2005

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this